140 filings
Page 6 of 7
8-K
lwcc0or
7 Dec 18
Entry into a Material Definitive Agreement
5:15pm
8-K
3p6j u6codk7
15 Nov 18
Akers Biosciences Announces Q3 2018 Earnings
7:00am
8-K
utdryywptl
9 Nov 18
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K/A
bgl4bhfn 6e5wape
2 Nov 18
Entry into a Material Definitive Agreement
12:15pm
8-K
gzinvjprn4jpabrja8vu
31 Oct 18
Entry into a Material Definitive Agreement
9:20am
8-K
7fw2xnq2 1h
19 Oct 18
Departure of Directors or Certain Officers
8:45am
8-K/A
pqie w11qmh9tdh3
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
8:15pm
8-K
px03ztbvafj
11 Oct 18
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
4:30pm
8-K
2xjbbak1
11 Sep 18
Departure of Directors or Certain Officers
12:00am
8-K
0jc3v 3o2tatdp9hrgvi
19 Jun 18
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:20pm
8-K
px5onew 24mjxp
15 Jun 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K/A
hzk1z rglu
5 Jun 18
Departure of Directors or Certain Officers
4:15pm
8-K
m6rndim1
1 Jun 18
Departure of Directors or Certain Officers
4:15pm
8-K
yb9p nd1fnci
31 May 18
Akers Biosciences Granted 180-Day Extension by Nasdaq
8:21am
8-K
bzp zhm88zhf24f
25 May 18
Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
5:00pm
8-K
zlxfe16hb2 gp8f3cuw
21 May 18
Other Events
5:20pm
8-K
n1k2iuf45rugo6j dh
25 Apr 18
Departure of Directors or Certain Officers
5:27pm
8-K
ftvw271az4h
26 Dec 17
Akers Biosciences Announces Closing of $6,900,000 Public Offering
12:00am
8-K
pg6s evpe9r5yyu5
19 Dec 17
Akers Biosciences Prices $6,000,000 Public Offering
12:00am
8-K
f3mt yyag
1 Dec 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am